Zura Bio Limited Stock Odds of Future Stock Price Finishing Over 2.22
| ZURA Stock | 2.28 0.06 2.56% |
Zura |
Zura Bio Target Price Odds to finish over 2.22
The tendency of Zura Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above 2.22 in 90 days |
| 2.28 | 90 days | 2.22 | roughly 96.0 |
Based on a normal probability distribution, the odds of Zura Bio to stay above 2.22 in 90 days from now is roughly 96.0 (This Zura Bio Limited probability density function shows the probability of Zura Stock to fall within a particular range of prices over 90 days) . Probability of Zura Bio Limited price to stay between 2.22 and its current price of 2.28 at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.49 . This usually means as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Zura Bio will likely underperform. Additionally Zura Bio Limited has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Zura Bio Price Density |
| Price |
Predictive Modules for Zura Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zura Bio Limited. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Zura Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Zura Bio is not an exception. The market had few large corrections towards the Zura Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Zura Bio Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Zura Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.87 | |
β | Beta against Dow Jones | 2.49 | |
σ | Overall volatility | 0.84 | |
Ir | Information ratio | -0.15 |
Zura Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Zura Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Zura Bio Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Zura Bio Limited generated a negative expected return over the last 90 days | |
| Zura Bio Limited has high historical volatility and very poor performance | |
| Net Loss for the year was (60.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zura Bio generates negative cash flow from operations | |
| Zura Bio Limited has a poor financial position based on the latest SEC disclosures | |
| About 32.0% of the company outstanding shares are owned by insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Robert Lisicki of 117000 shares of Zura Bio at 2.76 subject to Rule 16b-3 |
Zura Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Zura Stock often depends not only on the future outlook of the current and potential Zura Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zura Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.1 M | |
| Cash And Short Term Investments | 99.8 M |
Zura Bio Technical Analysis
Zura Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Zura Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Zura Bio Limited. In general, you should focus on analyzing Zura Stock price patterns and their correlations with different microeconomic environments and drivers.
Zura Bio Predictive Forecast Models
Zura Bio's time-series forecasting models is one of many Zura Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Zura Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Zura Bio Limited
Checking the ongoing alerts about Zura Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Zura Bio Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Zura Bio Limited generated a negative expected return over the last 90 days | |
| Zura Bio Limited has high historical volatility and very poor performance | |
| Net Loss for the year was (60.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zura Bio generates negative cash flow from operations | |
| Zura Bio Limited has a poor financial position based on the latest SEC disclosures | |
| About 32.0% of the company outstanding shares are owned by insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Robert Lisicki of 117000 shares of Zura Bio at 2.76 subject to Rule 16b-3 |
Check out Zura Bio Backtesting, Zura Bio Valuation, Zura Bio Correlation, Zura Bio Hype Analysis, Zura Bio Volatility, Zura Bio History as well as Zura Bio Performance. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.57 | Return On Assets (0.21) | Return On Equity (0.37) |
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.